RSLS - ReShape Lifesciences Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:

Balance Sheet

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Current Assets
Cash And Cash Equivalents5,547.74510,163.2083,310.7877,927.24
Short Term Investments----
Net Receivables916.813488.613143.69257.928
Inventory984.7351,968.5461,789.5781,686.324
Other Current Assets-848.566--
Total Current Assets8,719.03413,936.7165,720.68110,502.987
Long Term Investments----
Property, plant and equipment63.548341.976200.72326.296
Goodwill-14,004.573--
Intangible Assets36,927.22121,808.827--
Accumulated Amortization----
Other Assets562.86338,612.4571,119.405757.802
Deferred Long Term Asset Charges----
Total Assets46,272.66688,704.5497,040.80611,587.085
Current Liabilities
Accounts Payable1,626.5451,088.2711,311.706172.05
Short/Current Long Term Debt---717.391
Other Current Liabilities1,906.821---
Total Current Liabilities8,362.5427,043.7894,063.1214,486.028
Long Term Debt---549.791
Other Liabilities6,247.6865,293.89139.1192,877.817
Deferred Long Term Liability Charges----
Minority Interest----
Negative Goodwill----
Total Liabilities14,610.22812,337.684,102.247,913.636
Stockholders' Equity
Misc. Stocks Options Warrants----
Redeemable Preferred Stock----
Preferred Stock----
Common Stock87.7040.14727.3661.024
Retained Earnings-418,989.911-334,759.354-300,941.382-277,580.538
Treasury Stock----
Capital Surplus450,563.689411,125.061303,852.582281,252.963
Other Stockholder Equity----
Total stockholders' equity31,661.48276,365.8542,938.5663,673.449
Net Tangible Assets-5,265.73940,552.4542,938.5663,673.449